Matches in Nanopublications for { ?s ?p "[MYCN contributes to tumorigenesis, in part, by repressing miR-184, leading to increased levels of AKT2, a direct target of miR-184.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[MYCN contributes to tumorigenesis, in part, by repressing miR-184, leading to increased levels of AKT2, a direct target of miR-184.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[MYCN contributes to tumorigenesis, in part, by repressing miR-184, leading to increased levels of AKT2, a direct target of miR-184.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP807425.RAmK6c9n5ov6l6QDkQdnkClSbn5EfcovYCiaCsPiCU4Es130_assertion description "[MYCN contributes to tumorigenesis, in part, by repressing miR-184, leading to increased levels of AKT2, a direct target of miR-184.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP807425.RAmK6c9n5ov6l6QDkQdnkClSbn5EfcovYCiaCsPiCU4Es130_provenance.
- NP807426.RAv-t6DQFz1vG3uwDXkfUYiOpPYn0_b11pCWqyBADLiNc130_assertion description "[MYCN contributes to tumorigenesis, in part, by repressing miR-184, leading to increased levels of AKT2, a direct target of miR-184.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP807426.RAv-t6DQFz1vG3uwDXkfUYiOpPYn0_b11pCWqyBADLiNc130_provenance.